Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
venetoclax
.
Show all posts
Showing posts with label
venetoclax
.
Show all posts
Monday, October 5, 2015
AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with relapsed/refractory CLL with 17P deletion
›
AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced that a Phase 2 trial of its investigational medicine venetocla...
›
Home
View web version
